Guardant Health Raises 2023 Revenue Guidance To $553M-$556M Vs $549.06M Est.
Portfolio Pulse from Benzinga Newsdesk
Guardant Health has raised its full year 2023 revenue guidance to $553M-$556M, representing a growth of 23% to 24% compared to 2022. The company also expects 2023 operating expenses to be lower than 2022 due to efficiency measures and leveraging of existing infrastructure. However, free cash flow is expected to be approximately negative $350 million in 2023.
November 06, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guardant Health's raised revenue guidance for 2023 and expected decrease in operating expenses could be positive for the stock. However, the projected negative free cash flow could be a concern for investors.
The raised revenue guidance and expected decrease in operating expenses indicate a positive financial outlook for Guardant Health, which could boost investor confidence and potentially drive the stock price up. However, the projected negative free cash flow could be a concern for investors, potentially offsetting some of the positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100